Total Payments
$472.94
2021 Payments
$21.30
Companies
5
Transactions
25
Medicare Patients
7,396
Medicare Billing
$763,363
Payment Breakdown by Category
Food & Beverage$472.94 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $472.94 | 25 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $193.97 | 14 | $0 (2020) |
| Allergan Inc. | $136.50 | 3 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $76.66 | 5 | $0 (2019) |
| GlaxoSmithKline, LLC. | $46.46 | 2 | $0 (2021) |
| Astellas Pharma US Inc | $19.35 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $21.30 | 1 | GlaxoSmithKline, LLC. ($21.30) |
| 2020 | $29.57 | 2 | PFIZER INC. ($29.57) |
| 2019 | $69.13 | 4 | Janssen Pharmaceuticals, Inc ($43.97) |
| 2018 | $157.34 | 12 | PFIZER INC. ($124.65) |
| 2017 | $195.60 | 6 | Allergan Inc. ($136.50) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/23/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: RESPIRATORY | ||||||
| 02/07/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/30/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/11/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: RESPIRATORY | ||||||
| 07/18/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/20/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/06/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/19/2018 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $2.23 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 11/12/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $2.35 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/23/2018 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $1.95 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 09/21/2018 | PFIZER INC. | LYRICA (Drug), EUCRISA | Food and Beverage | In-kind items and services | $6.57 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 08/31/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $2.13 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/26/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $2.58 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/12/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/11/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/09/2018 | PFIZER INC. | LYRICA (Drug), EUCRISA | Food and Beverage | In-kind items and services | $6.29 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 03/01/2018 | PFIZER INC. | LYRICA (Drug), EUCRISA | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 02/07/2018 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/31/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $78.11 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/01/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Urology | ||||||
| 08/17/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2017 | PFIZER INC. | PREVNAR - 13 (Biological), TRUMENBA | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: VACCINES | ||||||
| 04/12/2017 | PFIZER INC. | PREVNAR - 13 (Biological), TRUMENBA | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: VACCINES | ||||||
| 04/11/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $102.16 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,763 | 2,808 | $662,853 | $217,720 |
| 2022 | 22 | 1,640 | 2,629 | $581,506 | $195,205 |
| 2021 | 17 | 1,490 | 2,205 | $479,055 | $175,975 |
| 2020 | 34 | 2,503 | 3,543 | $501,533 | $174,463 |
Total Patients
7,396
Total Services
11,185
Medicare Billing
$763,363
Procedure Codes
98
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 413 | 1,060 | $358,522 | $94,583 | 26.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 351 | 351 | $100,035 | $46,033 | 46.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 52 | 174 | $46,110 | $16,542 | 35.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 118 | 145 | $33,685 | $9,311 | 27.6% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 55 | 56 | $8,500 | $7,106 | 83.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 57 | 78 | $21,450 | $7,106 | 33.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 89 | 89 | $10,930 | $6,388 | 58.4% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 35 | 41 | $11,767 | $4,094 | 34.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 100 | 100 | $5,500 | $3,147 | 57.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $5,492 | $3,097 | 56.4% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 55 | 56 | $3,360 | $2,349 | 69.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 49 | 55 | $7,150 | $2,310 | 32.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 25 | 42 | $6,426 | $2,221 | 34.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 208 | 213 | $10,650 | $2,116 | 19.9% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 14 | 14 | $5,124 | $2,041 | 39.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 31 | $6,045 | $1,907 | 31.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $4,103 | $1,855 | 45.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 11 | $5,808 | $1,835 | 31.6% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 20 | 30 | $3,000 | $984.84 | 32.8% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 14 | 107 | $3,424 | $907.81 | 26.5% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 11 | 16 | $1,568 | $416.13 | 26.5% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 11 | 12 | $1,680 | $389.00 | 23.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $960.00 | $346.17 | 36.1% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 15 | 23 | $736.00 | $345.92 | 47.0% |
| 85610 | Blood test, clotting time | Office | 2023 | 11 | 69 | $828.00 | $289.80 | 35.0% |
About Dr. Matthew Loew, M.D
Dr. Matthew Loew, M.D is a Internal Medicine healthcare provider based in Attleboro, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730159187.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Loew, M.D has received a total of $472.94 in payments from pharmaceutical and medical device companies, with $21.30 received in 2021. These payments were reported across 25 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($472.94).
As a Medicare-enrolled provider, Loew has provided services to 7,396 Medicare beneficiaries, totaling 11,185 services with total Medicare billing of $763,363. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Attleboro, MA
- Active Since 01/26/2006
- Last Updated 02/11/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1730159187
Products in Payments
- NAMZARIC (Drug) $115.07
- ELIQUIS (Drug) $78.11
- XARELTO (Drug) $60.02
- CHANTIX (Drug) $47.85
- PREVNAR - 13 (Biological) $39.75
- LYRICA (Drug) $28.26
- TRELEGY ELLIPTA (Drug) $25.16
- VRAYLAR (Drug) $21.43
- ANORO ELLIPTA (Drug) $21.30
- Myrbetriq (Drug) $19.35
- INVOKANA (Drug) $16.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Attleboro
Sreekala Vasudevan, M.d, M.D
Internal Medicine — Payments: $21,120
Internal Medicine $21,120
Dr. Prabhu Ram, M.d, M.D
Internal Medicine — Payments: $9,012
Internal Medicine $9,012
David Cohen, Md, MD
Internal Medicine — Payments: $6,316
Internal Medicine $6,316
Dr. Chadi Kaba, M.d, M.D
Internal Medicine — Payments: $2,583
Internal Medicine $2,583
Asma Latif, M.d, M.D
Internal Medicine — Payments: $2,460
Internal Medicine $2,460
Dr. Glenn Tucker, M.d, M.D
Internal Medicine — Payments: $1,943
Internal Medicine $1,943